A detailed history of Xtx Topco LTD transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 24,416 shares of TSVT stock, worth $73,003. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,416
Previous 15,159 61.07%
Holding current value
$73,003
Previous $58,000 98.28%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.85 - $5.05 $35,639 - $46,747
9,257 Added 61.07%
24,416 $115,000
Q2 2024

Aug 12, 2024

SELL
$3.6 - $5.79 $13,219 - $21,260
-3,672 Reduced 19.5%
15,159 $58,000
Q1 2024

May 13, 2024

SELL
$3.09 - $6.0 $15,261 - $29,634
-4,939 Reduced 20.78%
18,831 $100,000
Q4 2023

Feb 13, 2024

SELL
$1.57 - $4.58 $30,242 - $88,224
-19,263 Reduced 44.76%
23,770 $101,000
Q3 2023

Nov 13, 2023

BUY
$3.14 - $11.2 $135,123 - $481,969
43,033 New
43,033 $168,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.